← Back to Search

Mineral Supplement

Magnesium Supplements for High Blood Pressure

N/A

Waitlist Available

Research Sponsored by Brigham and Women's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Total Mg intake from supplements of no more than 100 mg/day

Be older than 18 years old

Must not have

Unwillingness and/or inability to swallow 4 pills per day

History of type 1 or 2 diabetes

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Summary

This trial will test whether magnesium glycinate lowers blood pressure.

Who is the study for?

This trial is for adults with high blood pressure (systolic 120-149 mmHg or diastolic 80-94 mmHg) who are willing to keep their diet and supplement intake the same during the study. They must have a BMI under 35, not take more than 100 mg/day of magnesium supplements, and cannot be planning to move out of Boston within a year.

What is being tested?

The trial is testing if taking magnesium glycinate (480 mg/day) for three months can lower blood pressure. Participants will either receive this supplement or a placebo without knowing which one they're getting.

What are the potential side effects?

While not specified here, common side effects from magnesium supplements may include stomach upset, diarrhea, nausea, and vomiting. However, individual reactions can vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I take 100 mg or less of magnesium supplements daily.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I cannot or will not take 4 pills daily.

Select...

I have a history of diabetes (type 1 or 2).

Select...

I have not had any cancer, except for non-melanoma skin cancer, in the last 5 years.

Select...

I have a history of inflammatory bowel disease.

Select...

I have a history of kidney disease.

Select...

I am not pregnant, nursing, or planning to become pregnant during treatment.

Select...

I have had kidney failure in the past.

Select...

I have a history of heart disease, including heart attack, stroke, or procedures to improve blood flow to my heart.

Select...

I have had pancreatitis before.

Select...

I am unable to sign a consent form.

Select...

I have been on dialysis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: magnesiumActive Control1 Intervention

magnesium glycinate supplement, 480 mg/day

Group II: placeboPlacebo Group1 Intervention

placebo supplement

0 / 12Eligibility criteria met

Find a Location

Who is running the clinical trial?

Pure EncapsulationsIndustry Sponsor

1 Previous Clinical Trials

120 Total Patients Enrolled

Brigham and Women's HospitalLead Sponsor

1,653 Previous Clinical Trials

11,490,976 Total Patients Enrolled

Media Library

Magnesium Glycinate Supplement (Mineral Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT03688503 — N/A

High Blood Pressure Research Study Groups: magnesium, placebo

High Blood Pressure Clinical Trial 2023: Magnesium Glycinate Supplement Highlights & Side Effects. Trial Name: NCT03688503 — N/A

Magnesium Glycinate Supplement (Mineral Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03688503 — N/A

~3 spots leftby Dec 2024

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.